We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+4.83%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$46B
AUM Growth
+$2.18B
(+5%)
Cap. Flow
+$425M
Cap. Flow
% of AUM
0.92%
Top 10 Holdings %
Top 10 Hldgs %
15.17%
Holding
2,954
New
28
Increased
2,252
Reduced
604
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$128M |
| 2 |
Baker Hughes
BKR
|
+$26.7M |
| 3 |
IQVIA
IQV
|
+$14.5M |
| 4 |
Oneok
OKE
|
+$14.3M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$11.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$114M |
| 2 |
RAI
Reynolds American Inc
RAI
|
+$88.6M |
| 3 |
BHI
Baker Hughes
BHI
|
+$41.6M |
| 4 |
WFM
Whole Foods Market Inc
WFM
|
+$26.7M |
| 5 |
UnitedHealth
UNH
|
+$22.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.64% |
| 2 | Technology | 15.8% |
| 3 | Healthcare | 13.57% |
| 4 | Industrials | 10.87% |
| 5 | Consumer Discretionary | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Kulicke & Soffa
KLIC
$4.67B
| $1.3M | ﹤0.01% |
60,319
+2,100
| +4% | +$42.1K |
|
1852
Medifast
MED
$109M
| $1.3M | ﹤0.01% |
21,831
+347
| +2% | +$17.3K |
|
|
HIFR
1853
DELISTED
InfraREIT, Inc.
HIFR
| $1.29M | ﹤0.01% |
57,841
+95
| +0.2% | +$2.04K |
|
|
STBZ
1854
DELISTED
State Bank Financial Corporation. Common Stock
STBZ
| $1.29M | ﹤0.01% |
45,148
+220
| +0.5% | +$5.95K |
|
|
EGL
1855
DELISTED
Engility Holdings, Inc.
EGL
| $1.29M | ﹤0.01% |
37,220
+124
| +0.3% | +$3.77K |
|
|
FARO
1856
DELISTED
Faro Technologies
FARO
| $1.29M | ﹤0.01% |
33,639
+305
| +0.9% | +$11K |
|
1857
Moelis & Co
MC
$4.97B
| $1.28M | ﹤0.01% |
29,832
+3,611
| +14% | +$144K |
|
|
SASR
1858
DELISTED
Sandy Spring Bancorp Inc
SASR
| $1.28M | ﹤0.01% |
30,942
+160
| +0.5% | +$6.29K |
|
1859
Cytokinetics
CYTK
$10.5B
| $1.28M | ﹤0.01% |
88,056
+5,470
| +7% | +$74.7K |
|
1860
Amphastar Pharmaceuticals
AMPH
$879M
| $1.27M | ﹤0.01% |
71,233
+1,470
| +2% | +$24.2K |
|
1861
Donnelley Financial Solutions
DFIN
$1.16B
| $1.27M | ﹤0.01% |
58,978
+3,286
| +6% | +$71.2K |
|
|
SAFE
1862
Safehold
SAFE
$1.16B
| $1.27M | ﹤0.01% |
22,130
+362
| +2% | +$20.8K |
|
|
TIER
1863
DELISTED
TIER REIT, Inc.
TIER
| $1.27M | ﹤0.01% |
65,834
-887
| -1% | -$16.3K |
|
1864
Caesars Entertainment
CZR
$6.06B
| $1.27M | ﹤0.01% |
49,427
+715
| +1% | +$15.9K |
|
1865
TTEC Holdings
TTEC
$121M
| $1.27M | ﹤0.01% |
30,373
+290
| +1% | +$11.7K |
|
|
LDR
1866
DELISTED
Landauer Inc
LDR
| $1.26M | ﹤0.01% |
18,767
+442
| +2% | +$26.7K |
|
|
AHRT
1867
AH Realty Trust
AHRT
$529M
| $1.26M | ﹤0.01% |
91,260
+1,425
| +2% | +$19K |
|
|
CACQ
1868
DELISTED
Caesars Acquisition Company
CACQ
| $1.26M | ﹤0.01% |
58,747
+320
| +0.5% | +$6.19K |
|
|
CTRL
1869
DELISTED
Control4 Corporation
CTRL
| $1.25M | ﹤0.01% |
42,571
+16,288
| +62% | +$397K |
|
1870
SunCoke Energy
SXC
$720M
| $1.25M | ﹤0.01% |
136,323
+2,530
| +2% | +$23.8K |
|
1871
AngioDynamics
ANGO
$611M
| $1.25M | ﹤0.01% |
72,870
+2,900
| +4% | +$48.7K |
|
|
KND
1872
DELISTED
Kindred Healthcare
KND
| $1.24M | ﹤0.01% |
182,112
+3,181
| +2% | +$27.1K |
|
|
WSTC
1873
DELISTED
West Corporation
WSTC
| $1.23M | ﹤0.01% |
52,578
-222
| -0.4% | -$5.19K |
|
1874
Modine Manufacturing
MOD
$10.7B
| $1.23M | ﹤0.01% |
63,717
+370
| +0.6% | +$6.2K |
|
|
LTRPA
1875
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $1.23M | ﹤0.01% |
99,382
-770
| -0.8% | -$9.57K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2017 Portfolio in Review
As of Q3 2017, RhumbLine Advisers held 2,954 positions worth $46B, up 5% from $43.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q3 2017: portfolio turnover was 2.6%. RhumbLine Advisers opened 28 new positions and exited 50, leaving the 2,954-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
- RhumbLine Advisers's largest Q3 2017 buy was Baker Hughes: 750,985 shares worth $27.5M.
- RhumbLine Advisers added most to DuPont de Nemours in Q3 2017, an estimated $128M increase.
- RhumbLine Advisers's biggest Q3 2017 reduction was UnitedHealth, cutting an estimated $22.8M.
- RhumbLine Advisers fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $114M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $46B portfolio in Q3 2017.
- RhumbLine Advisers opened 28 new positions and closed 50 in Q3 2017.
- RhumbLine Advisers's portfolio value rose 5% quarter-over-quarter to $46B.
Based on RhumbLine Advisers's 13F filing for Q3 2017, filed 6 Nov 2017.